MedTech Innovator Announces 2025 Mid-Stage Prize and Value Award Finalists
LOS ANGELES – October 30, 2025 – MedTech Innovator (MTI), the world’s largest and most impactful accelerator for medical technology startups, today announced the finalists in its Mid-Stage and Value Award Competitions.
The 2025 Mid-Stage and Value Award competitions will take place during the MedTech Strategist Innovation Summit in San Diego, with the Value Award Competition taking place on Wednesday, November 19, at 4:40 p.m., and the Mid-Stage Competition finals taking place on Thursday, November 20, at 5:10 p.m. During the competitions, each company will pitch their technology and answer questions from a panel of judges. After the presentations, the audience will vote in real-time to select the winner.
The Mid-Stage Finals Competition was launched in 2023 to allow more mature companies in the accelerator cohort to compete for recognition and cash awards. The mid-stage companies were chosen based on their value propositions, achievements to date, and likelihood to transform care. Each finalist will receive at least $25,000 in funding and have the chance to compete for the $200,000 Mid-Stage Grand Prize Award.
The four finalists who will compete for the 2025 Mid-Stage Prize are:
- BRIJ Medical (Marietta,G.A.): Brijjit’s non-invasive tissue bridges are redefining closure and patient healing—eliminating up to 100% of incision tension to reduce open wounds by 90%* and scar size by 38%*
- MedCu (Herzliya, Israel): MedCu’s wound healing dressings release copper ions that stimulate production of new blood capillaries and protect the wound from infraction
- Multiphze (Glendale, Calif.): First OSHA complaint device to manually irrigate and remove bloody urine from the bladder reducing exposure risk and cost
- Powerful Medical (New York City): AI ECG diagnostics and care-coordination platform with 2x sensitivity on heart attacks compared to standard of care (+38 dg)
“We’re thrilled to bring the finalists in our Mid-Stage and Value Award competitions to the MedTech Strategist Innovation Summit in San Diego,” said Paul Grand, CEO of MedTech Innovator. “Showcasing our Finalists at the Summit gives them unparalleled visibility to decision-makers at strategics, investors, providers, and payers who will vote to choose the winners of our $200,000 Mid-Stage Grand Prize and the $25,000 Value Award.”
Additionally, five finalists will compete for the $25,000 Value Award, recognizing the development of outstanding value propositions in their respective clinical areas. All participants in the MedTech Innovator accelerator had the opportunity to refine their value propositions over several months with input from MTI’s 37 value coaches. The value coaches nominated 28 companies for the finals, from which 13 were shortlisted for consideration, followed by a vote by MTI’s selection committee.
The five finalists for the 2025 Value Award are:
- InSomaBio (Durham, N.C.): We Make Fat Amazing
- Stentit (Eindhoven, Germany): The RFS not only opens up arteries but also triggers the reconstruction of a new artery from the inside-out, as it resorbs
- VQ Biomedical (Raleigh, N.C.): A minimally-invasive catheter that safely diffuses oxygen directly into the bloodstream in patients with respiratory failure
- Wavelet (New Haven, Conn.): A novel, noninvasive fetal EEG technology that detects real-time fetal distress to improve outcomes for mother and baby
- Winter Innovations (Knoxville, Tenn.): A two-part needle system that reduces steps and strengthens stitching in orthopedic soft tissue surgery
MTI tapped over 500 subject matter experts to evaluate thousands of applicants and mentor the best-in-class 64 companies participating in MTI’s flagship four-month US market-focused accelerator program. Featuring 45 early-stage and 19 mid-stage medical device, diagnostic, and digital health companies from around the globe, the 2025 cohort company leadership teams received unparalleled mentoring, networking, and access to the resources that only MTI’s world-leading ecosystem of strategic manufacturers, investors, healthcare providers, payers, patients, and other industry stakeholders can offer.
About MedTech Innovator
MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 800 graduates. Alumni have collectively raised $10+ billion in follow-on funding and introduced 500+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.
# # #
Media Contact
Jenna Kane
Health+Commerce
jennakane@healthandcommerce.com
